ECB approves €1 trillion program to overcome coronavirus crisis
European Central Bank President Christine Lagarde has announced that the ECB will be printing 1 trillion EUR to help the region overcome the coronavirus crisis, with hard-hit Italy needing lower borrowing costs to fund efforts to combat the spread of the contagious infection, for which the ECB has decided to increase its spending by 1.1 trillion EUR, worth over 6 percent of the eurozone's total GDP.
italy europe euro gdp spending trillion european-union infection coronavirus pandemic covid-19 eurozone
ReutersRelated Articles
Shell Gas Station security guard attacked by three men asked to wear a mask
LOUIS – A security guard at a Shell Gas Station was attacked by three men who were asked to leave for not wearing masks. Police said the victim then grabbed his gun from his holster and fired at the suspects causing them to flee the scene. The suspect was listed in critical/stable condition.
gun pandemic mask firearm
Fox2now
Bank of England holds interest rate at 0.1%
In an important announcement on Thursday, the Bank of England held interest rates steady and maintained its existing level of asset purchases, as investors watched for signs that it is anticipating a slower economic recovery. The main lending rate was kept at 0.1%, as the central bank cut rates twice from 0.75% since the beginning of the coronavirus pandemic
rates coronavirus interest boe
CNBC
US posted the worst-ever GDP plunge
US posted the worst-ever GDP plunge
US GDP dropped 32.9% in the second quarter, the worst ever posted in the Q2. Economists surveyed by Dow Jones had been looking for a drop of 34.7% but still, it was the worst drop ever, with the closest previously coming in mid-1921. The report comes amid a recession that began in February and pulled first-quarter growth down 5%. On a quarterly basis, the Q2 decline was 1.8%
us economy markets gdp
CNBC
Moderna, Pfizer Start Decisive Covid Vaccine Trials
Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday. The trials, both announced on Monday, are the first late-stage studies supported by the Trump administration's effort to speed development of measures against the novel coronavirus.
vaccine coronavirus
Ndtv